Physician profile
Robert A Pick
NPI 1982670592
$10,265.57
in general payments reported to CMS, 2019-2025
27 companies · $1,010 in 2025
The $1,010 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $843 · 2021: $1,707 · 2022: $3,372 · 2023: $1,571 · 2024: $752 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,968 · Travel and Lodging: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,968.42 |
| Travel and Lodging | $363.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,538.28 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Crome Dr Mri Surescan |
| Boston Scientific Corporation | $1,159.25 | 2019-2024 | Watchman Flx, Synergy, Comet |
| Abbott Laboratories | $1,002.41 | 2019-2025 | Xience Skypoint, Optis, Nc Trek Neo |
| Medtronic Vascular, INC. | $560.16 | 2019-2020 | |
| Abiomed | $490.29 | 2019-2024 | Impella |
| Amgen INC. | $280.04 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $185.90 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals Lp | $152.41 | 2019-2025 | Farxiga |
| Edwards Lifesciences Corporation | $133.56 | 2023-2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $113.71 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $113.05 | 2019 | |
| Biotronik INC. | $89.85 | 2023-2025 | Edora 8 Dr-T, Acticor 7 Vr-T Dx, Pamira |
| Amarin Pharma, INC. | $57.91 | 2019 | |
| Alnylam Pharmaceuticals INC. | $52.59 | 2025 | Amvuttra |
| Cathworks, INC. | $48.73 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $43.31 | 2020 | |
| Novartis Pharmaceuticals Corporation | $40.18 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $36.41 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.43 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $22.12 | 2020 | |
| Kestra Medical Technology Services, INC. | $18.24 | 2025 | Assure Wcd |
| Cvrx, INC. | $17.53 | 2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $17.37 | 2025 | Nexletol |
| Cordis US Corp. | $17.22 | 2022 | |
| Cardinal Health 200 LLC | $16.16 | 2019 | |
| Baxter Healthcare | $15.83 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.